Wolverine Trading
ABEO icon

Wolverine Trading’s Abeona Therapeutics ABEO Stock Holding History

Wolverine Trading’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-494
Closed -$23K – 5709
2021
Q1 		$23K Buy
494
+69
+16% +$3.8K ﹤0.01% 5744
2020
Q4 		$17K Buy
+425
New +$14.5K ﹤0.01% 4698
2019
Q4 		– Sell
-470
Closed -$33.2K – 4578
2019
Q3 		$29K Sell
470
-439
-48% -$32.9K ﹤0.01% 4135
2019
Q2 		$109K Buy
+909
New +$152K ﹤0.01% 3988

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Wolverine Trading's ABEO Position: Q2 2021 in Review

Wolverine Trading sold out of Abeona Therapeutics (ABEO) in Q2 2021, closing a stake of 494 shares — an estimated $23K sold.

Wolverine Trading first reported a position in ABEO in Q2 2019 and held it in 4 quarters. The position peaked at $109K in Q2 2019. 70 funds tracked by Wall St. Rank hold ABEO as of Q2 2021.

  • Wolverine Trading reported no remaining Abeona Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 494 Abeona Therapeutics shares in Q2 2021, an estimated $23K.
  • Wolverine Trading first reported a position in Abeona Therapeutics in Q2 2019 and held it in 4 quarters.
  • Wolverine Trading's Abeona Therapeutics position peaked at $109K in Q2 2019.
  • 70 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.